Both in Biotechnology
Atara Biotherapeutics vs Champions Oncology
Over the past year ATRA returned −43.1% and CSBR returned −27.6%; their daily moves had a correlation of 0.06.
ATRA −43.1% CSBR −27.6%Growth of $1, one year, split-adjusted
| Metric | ATRA | CSBR |
|---|---|---|
| Price | $8.66 | $4.92 |
| Market cap | $86.9M | $68.5M |
| Today | +4.34% | +1.86% |
| 1 month | +7.6% | +2.7% |
| 6 months | +88.3% | −15.9% |
| Year to date | −52.1% | −28.8% |
| 1 year | −44.5% | — |
| Revenue growth (YoY) | −96.4% | +8.8% |
| Gross margin | 69.7% | 50.5% |
| Net margin | −767.3% | −2.8% |
| P/E (TTM) | — | — |
| Price / sales | 14.0× | 1.1× |
| Net cash | $9.9M | $4.4M |
| Dividend yield | — | — |
| Volatility (60d) | 63.6% | 35.8% |
| Short % of float | 11.2% | 1.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).